Skip to content

Clinical trials

Weight Gain trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Weight Gain Clear all

301 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20012
20023
20037
20043
20058
200611
200717
200818
20097
201013
201114
201211
201310
20147
201510
201615
201713
201816
201917
20208
202115
202219
202319
202416
20255
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed195
Unknown status37
Recruiting24
Terminated18
Not yet recruiting11
Withdrawn9
Active, not recruiting5
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)8
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)6
Stanford University6
University of Michigan6
University of North Carolina, Chapel Hill5
University of Pennsylvania5
Washington University School of Medicine5
VA Office of Research and Development4
Charite University, Berlin, Germany3
Corcept Therapeutics3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Weight Gain301
Obesity112
Weight Loss32
Schizophrenia26
Overweight21
Psychotic Disorders17
Metabolic Syndrome15
Diabetes Mellitus14
Gestational Weight Gain12
Insulin Resistance12

Trials

Showing 76 to 100 of 301. Each trial links to its page on Pharma Observatory.

201 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.